Pfizer earnings jump on strong sales of COVID-19 vaccine, Paxlovid drug

📆 2022/07/29 2:32:00
📰 ChannelNewsAsia

⏱ Reading Time:
10 sec. here
2 min. at publisher
📊 Quality Score:
News: 7%
Publisher: 66%

日本ニュースニュース

日本最新ニュース,日本見出し

NEW YORK: Pfizer reported a jump in second-quarter profits on Thursday (Jul 28) behind a near doubling of revenues driven by sales of its COVID-19 vaccine and therapeutic drug Paxlovid. The drugmaker raised some of its overall financial benchmarks, but maintained 2022 sales targets for its two COVID-19 pro

NEW YORK: Pfizer reported a jump in second-quarter profits on Thursday behind a near doubling of revenues driven by sales of its COVID-19 vaccine and therapeutic drug Paxlovid.

US officials last month approved emergency authorisation to Pfizer and Moderna for COVID-19 vaccines in under-five-year-olds, the final age group awaiting immunisation in most countries.

コメントを書く

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。続きを読む:

日本 最新ニュース, 日本 見出し

日本最新ニュース, 日本見出し